Financhill
Sell
28

GH Quote, Financials, Valuation and Earnings

Last price:
$40.59
Seasonality move :
14.13%
Day range:
$39.14 - $42.16
52-week range:
$15.81 - $50.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.74x
P/B ratio:
32.59x
Volume:
1.9M
Avg. volume:
2.1M
1-year change:
123.58%
Market cap:
$5B
Revenue:
$739M
EPS (TTM):
-$3.56

GH Analysts' Consensus Rating

The 16 analysts providing 12-month price projections for Guardant Health shares anticipate an average target of $56.85, ranging from a low estimate of $47.00 to a high estimate of $65.00. This average target implies a growth of 40.09% compared to the current stock price of $40.58.

Consensus Price Target

$56.85

Highest Price Target

$65.00

Lowest Price Target

$47.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 14 14 14

Hold 1 2 2

Sell 0 0 0
Consensus Buy Buy Buy

GH Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock